These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 12538625

  • 1. Resistance of human ovarian cancer cells to tumor necrosis factor alpha is a consequence of nuclear factor kappaB-mediated induction of Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory protein.
    Xiao CW, Yan X, Li Y, Reddy SA, Tsang BK.
    Endocrinology; 2003 Feb; 144(2):623-30. PubMed ID: 12538625
    [Abstract] [Full Text] [Related]

  • 2. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S, Meyer E, Debatin KM.
    Cancer Res; 2000 Jul 15; 60(14):3947-56. PubMed ID: 10919673
    [Abstract] [Full Text] [Related]

  • 3. Nuclear factor kappaB-mediated induction of Flice-like inhibitory protein prevents tumor necrosis factor alpha-induced apoptosis in rat granulosa cells.
    Xiao CW, Asselin E, Tsang BK.
    Biol Reprod; 2002 Aug 15; 67(2):436-41. PubMed ID: 12135878
    [Abstract] [Full Text] [Related]

  • 4. NF-kappaB-regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts from tumor necrosis factor alpha-mediated apoptosis.
    Bai S, Liu H, Chen KH, Eksarko P, Perlman H, Moore TL, Pope RM.
    Arthritis Rheum; 2004 Dec 15; 50(12):3844-55. PubMed ID: 15593196
    [Abstract] [Full Text] [Related]

  • 5. Differential regulation of Fas-mediated apoptosis of rheumatoid synoviocytes by tumor necrosis factor alpha and basic fibroblast growth factor is associated with the expression of apoptosis-related molecules.
    Kobayashi T, Okamoto K, Kobata T, Hasunuma T, Kato T, Hamada H, Nishioka K.
    Arthritis Rheum; 2000 May 15; 43(5):1106-14. PubMed ID: 10817565
    [Abstract] [Full Text] [Related]

  • 6. c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis.
    Mathas S, Lietz A, Anagnostopoulos I, Hummel F, Wiesner B, Janz M, Jundt F, Hirsch B, Jöhrens-Leder K, Vornlocher HP, Bommert K, Stein H, Dörken B.
    J Exp Med; 2004 Apr 19; 199(8):1041-52. PubMed ID: 15078899
    [Abstract] [Full Text] [Related]

  • 7. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma.
    Mezzanzanica D, Balladore E, Turatti F, Luison E, Alberti P, Bagnoli M, Figini M, Mazzoni A, Raspagliesi F, Oggionni M, Pilotti S, Canevari S.
    Clin Cancer Res; 2004 Aug 01; 10(15):5202-14. PubMed ID: 15297424
    [Abstract] [Full Text] [Related]

  • 8. Possible role of FLICE-like inhibitory protein (FLIP) in chemoresistant ovarian cancer cells in vitro.
    Abedini MR, Qiu Q, Yan X, Tsang BK.
    Oncogene; 2004 Sep 16; 23(42):6997-7004. PubMed ID: 15258564
    [Abstract] [Full Text] [Related]

  • 9. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis.
    Kim JH, Ajaz M, Lokshin A, Lee YJ.
    Clin Cancer Res; 2003 Aug 01; 9(8):3134-41. PubMed ID: 12912965
    [Abstract] [Full Text] [Related]

  • 10. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
    Chatterjee D, Schmitz I, Krueger A, Yeung K, Kirchhoff S, Krammer PH, Peter ME, Wyche JH, Pantazis P.
    Cancer Res; 2001 Oct 01; 61(19):7148-54. PubMed ID: 11585748
    [Abstract] [Full Text] [Related]

  • 11. Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells.
    Lane D, Cartier A, L'Espérance S, Côté M, Rancourt C, Piché A.
    Gynecol Oncol; 2004 Jun 01; 93(3):594-604. PubMed ID: 15196850
    [Abstract] [Full Text] [Related]

  • 12. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
    Herr I, Ucur E, Herzer K, Okouoyo S, Ridder R, Krammer PH, von Knebel Doeberitz M, Debatin KM.
    Cancer Res; 2003 Jun 15; 63(12):3112-20. PubMed ID: 12810637
    [Abstract] [Full Text] [Related]

  • 13. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW, Shah S.
    Asia Pac J Clin Nutr; 2005 Jun 15; 14(4):366-73. PubMed ID: 16326643
    [Abstract] [Full Text] [Related]

  • 14. Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells.
    Mitsiades N, Mitsiades CS, Poulaki V, Anderson KC, Treon SP.
    Blood; 2002 Mar 15; 99(6):2162-71. PubMed ID: 11877293
    [Abstract] [Full Text] [Related]

  • 15. Resistance to TRAIL-induced apoptosis in ovarian cancer cell lines is overcome by co-treatment with cytotoxic drugs.
    Tomek S, Horak P, Pribill I, Haller G, Rössler M, Zielinski CC, Pils D, Krainer M.
    Gynecol Oncol; 2004 Jul 15; 94(1):107-14. PubMed ID: 15262127
    [Abstract] [Full Text] [Related]

  • 16. Nuclear factor-kappaB-mediated X-linked inhibitor of apoptosis protein expression prevents rat granulosa cells from tumor necrosis factor alpha-induced apoptosis.
    Xiao CW, Ash K, Tsang BK.
    Endocrinology; 2001 Feb 15; 142(2):557-63. PubMed ID: 11159825
    [Abstract] [Full Text] [Related]

  • 17. Jun kinase modulates tumor necrosis factor-dependent apoptosis in liver cells.
    Liedtke C, Plümpe J, Kubicka S, Bradham CA, Manns MP, Brenner DA, Trautwein C.
    Hepatology; 2002 Aug 15; 36(2):315-25. PubMed ID: 12143039
    [Abstract] [Full Text] [Related]

  • 18. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis.
    Hatano E, Bennett BL, Manning AM, Qian T, Lemasters JJ, Brenner DA.
    Gastroenterology; 2001 Apr 15; 120(5):1251-62. PubMed ID: 11266388
    [Abstract] [Full Text] [Related]

  • 19. Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression.
    Grotzer MA, Eggert A, Zuzak TJ, Janss AJ, Marwaha S, Wiewrodt BR, Ikegaki N, Brodeur GM, Phillips PC.
    Oncogene; 2000 Sep 21; 19(40):4604-10. PubMed ID: 11030149
    [Abstract] [Full Text] [Related]

  • 20. The von Hippel-Lindau tumor suppressor protein sensitizes renal cell carcinoma cells to tumor necrosis factor-induced cytotoxicity by suppressing the nuclear factor-kappaB-dependent antiapoptotic pathway.
    Qi H, Ohh M.
    Cancer Res; 2003 Nov 01; 63(21):7076-80. PubMed ID: 14612498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.